Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article appearing in Nashville Medical News and shared by Tennessee Oncology and OneOncology, titled “The Oncology Care Model Value Proposition,” highlighted 2 meetings, Patient-Centered Oncology Care® in Philadelphia, Pennsylvania, and the Institute for Value-Based Medicine® (IVBM) in Nashville, Tennessee, conducted by The American Journal of Managed Care® (AJMC®). The article spotlighted the presentation of featured IVBM speaker Stephen Schleicher, MD, MBA, physician and Tennessee Oncology’s chair of the Quality and Value Committee at OneOncology.
Endpoints News referenced an article from AJMC®’s sister site, The Center for Biosimilars®, titled “AbbVie and Boehringer Ingelheim Settle Over Biosimilar Adalimumab.” The article detailed the announcement of AbbVie's patent litigation settlement with Boehringer Ingelheim over the biosimilar Cyltezo, which references AbbVie’s originator adalimumab, Humira.
Another article from The Center for Biosimilars® was also featured in the November 18, 2019 daily regulatory news and intelligence briefing from Regulatory Focus. The article, “Biosimilars Make Progress in the Canadian Market, but Stakeholders See More Work Ahead,” was included in the In Focus: International section. The article emphasized strides made by Canada in its biosimilar experience.
An article in Williston Herald, “A New Way to Fight Breast Cancer,” highlighted an AJMC® article, “FDA Approves First Breast Cancer Drug to Target PIK3CA Mutation Plus Companion Diagnostic Test.” The article covered the announcement by the FDA of the approval for the novel oral drug alpelisib, sold as Piqray.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More